RecruitingNCT05740683

Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA


Sponsor

Danish Dementia Research Centre

Enrollment

100 participants

Start Date

Feb 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Test of early warning signs and RT-QuIC in patients with idiopathic olfactory dysfunction


Eligibility

Min Age: 55 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether a specific protein linked to Parkinson's disease (alpha-synuclein) can be detected in people who have lost their sense of smell for no known reason (called idiopathic olfactory dysfunction). Loss of smell can sometimes be an early sign of Parkinson's disease years before movement problems begin. **You may be eligible if...** - You are between 55 and 75 years old - You have a slowly progressing, unexplained loss of smell (not due to allergies, nasal disease, injury, or surgery) - You have not been diagnosed with a neurodegenerative disease such as Parkinson's or dementia - You are able to give informed consent - (Healthy volunteers without smell problems are also eligible as controls) **You may NOT be eligible if...** - You already have a diagnosed neurological or psychiatric condition - Your smell loss is due to a known cause (such as chronic sinusitis, trauma, or medication) - You show obvious signs of dementia or Parkinson's disease - You have severe nasal abnormalities or active infections - You currently abuse alcohol or drugs Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTRT-QuiC

RT-QuIC measures the ability of aSyn to misfold other aSyn proteins and is an amplification technique.


Locations(2)

Danish Dementia Research Centre

Copenhagen, Denmark

Oskar McWilliam

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05740683